Global Technologies LTD 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

OTC.Pink
Global Technologies, Ltd. filed its Q3 2026 Form 10-Q, detailing a strategic shift towards its healthcare and technology-enabled services subsidiaries, Primecare Supply and GTLL Advisory, while reporting a net loss.
OTC.Pink
Global Technologies, Ltd. filed an amended quarterly report for Q2 2026, revealing a net loss for the quarter and a significant revenue decline, alongside a strategic pivot in its core operations.
OTC.Pink
Global Technologies, Ltd. reported a significant decline in revenue and a net loss for the six months ended December 31, 2025, as it navigates a strategic shift in its core health-tech operations.
OTC.Pink
Global Technologies reported a significant revenue decline in Q1 2026, driven by a strategic shift in its health and wellness operations and the termination of its EV charging station acquisition.
OTC.Pink
Global Technologies, Ltd. reports a significant increase in revenue for Q3 2025 driven by its health and wellness initiatives, while strategically reducing investment in its EV infrastructure sector.
OTC.Pink
Global Technologies, Ltd. reports a profitable second quarter driven by significant revenue generation from its 10 Fold Services subsidiary.
OTC.Pink
Global Technologies, Ltd. reports a net income of $256,549 for the quarter ended September 30, 2024, driven by revenue from its subsidiary 10 Fold Services.
OTC.Pink
Global Technologies, Ltd reported a net income of $526,230 for the nine months ended March 31, 2024, a significant turnaround from a net loss in the same period last year, primarily due to increased revenue and gains on derivative liabilities.
OTC.Pink
Global Technologies, Ltd. reported its financial results for the quarter ended December 31, 2023, alongside updates on a significant acquisition and strategic business changes.